Delivery Order SPE2DB22D3010-SPE2DB25FP2NC
Award Date
5/21/25
Potential Completion Date
6/12/25
Potential Value
$5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,012.70 firm fixed-price delivery order is for PROQUAD VIALS, with an ultimate completion date of April 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,404.90 firm fixed-price delivery order is for PROQUAD VIALS, a type of medical product, with a period of performance through April 3, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,654.33, is a delivery order for PROQUAD VIALS and has a completion date of February 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,570.54 firm fixed-price delivery order is for the provision of PROQUAD VIALS, a medical product. The contract has an ultimate completion date of August 7, 2024 and was awarded on July 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,687.48 Firm Fixed Price delivery order contract is for the procurement of PROQUAD VIALS, with a period of performance through March 17, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,654.33 firm fixed-price delivery order is for PROQUAD VIALS, a pharmaceutical product, with a period of performance through February 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, the prime contractor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,601.99 firm fixed-price delivery order is for the supply of PROQUAD VIALS, a pharmaceutical product. The contract has a completion date of September 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, is supplying these medical commodities to support military treatment programs and facilities worldwide through a large...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of PROQUAD VIALS, medical supplies valued at $7,167.50. The award, which is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, has a firm fixed price and an ultimate completion date of September 6, 2022. The contract does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,086.60 firm fixed-price delivery order is for the supply of 4568267436 PROQUAD VIALS, a pharmaceutical product, with a performance period extending through June 4, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,341.80 firm fixed-price delivery order is for PROQUAD VIALS and has an ultimate completion date of January 28, 2025. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...